Colgate-Palmolive (NYSE:CL) is finally on sale. The company's shares have fallen 15% since hitting a high back in May. Is this the dip that sidelined investors have been waiting for?
In the video below, Fool contributor Demitrios Kalogeropoulos argues that, while Colgate can still seem expensive compared to consumer goods rivals Procter & Gamble (NYSE:PG) and Clorox (NYSE:CLX), it brings a few qualities to the table that make it worth that premium. For example, the company is boosting its already dominant market-share position in key products, and its heavy exposure to international business is a source of profit growth. Demitrios sees this recent sell-off as a chance for long-term investors to get into a high-quality dividend stock at a reasonable price.
Fool contributor Demitrios Kalogeropoulos has no position in any stocks mentioned. The Motley Fool recommends Procter & Gamble. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.